GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (BSP:REGN34) » Definitions » Cyclically Adjusted Book per Share

Regeneron Pharmaceuticals (BSP:REGN34) Cyclically Adjusted Book per Share : R$8.48 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Regeneron Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Regeneron Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2023 was R$19.385. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$8.48 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Regeneron Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 27.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 33.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 32.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 33.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Regeneron Pharmaceuticals was 35.90% per year. The lowest was -4.00% per year. And the median was 5.30% per year.

As of today (2024-05-01), Regeneron Pharmaceuticals's current stock price is R$75.05. Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was R$8.48. Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 8.85.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Regeneron Pharmaceuticals was 62.14. The lowest was 7.04. And the median was 15.29.


Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 3.96 5.97 7.51 8.48

Regeneron Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.51 7.77 7.78 8.87 8.48

Competitive Comparison of Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Regeneron Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=19.385/129.4194*129.4194
=19.385

Current CPI (Dec. 2023) = 129.4194.

Regeneron Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.850 99.695 1.103
201406 0.869 100.560 1.118
201409 0.973 100.428 1.254
201412 1.096 99.070 1.432
201503 1.507 99.621 1.958
201506 1.671 100.684 2.148
201509 2.061 100.392 2.657
201512 2.259 99.792 2.930
201603 2.210 100.470 2.847
201606 2.209 101.688 2.811
201609 2.309 101.861 2.934
201612 2.346 101.863 2.981
201703 2.387 102.862 3.003
201706 2.831 103.349 3.545
201709 2.942 104.136 3.656
201712 3.135 104.011 3.901
201803 3.328 105.290 4.091
201806 4.184 106.317 5.093
201809 4.979 106.507 6.050
201812 5.200 105.998 6.349
201903 5.517 107.251 6.657
201906 5.711 108.070 6.839
201909 6.573 108.329 7.853
201912 6.879 108.420 8.211
202003 8.807 108.902 10.466
202006 7.387 108.767 8.790
202009 8.547 109.815 10.073
202012 8.839 109.897 10.409
202103 10.548 111.754 12.215
202106 11.880 114.631 13.413
202109 13.994 115.734 15.649
202112 16.277 117.630 17.908
202203 15.083 121.301 16.092
202206 15.894 125.017 16.454
202209 17.221 125.227 17.798
202212 18.078 125.222 18.684
202303 18.593 127.348 18.895
202306 17.841 128.729 17.937
202309 18.838 129.860 18.774
202312 19.385 129.419 19.385

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Regeneron Pharmaceuticals  (BSP:REGN34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=75.05/8.48
=8.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Regeneron Pharmaceuticals was 62.14. The lowest was 7.04. And the median was 15.29.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals (BSP:REGN34) Business Description

Traded in Other Exchanges
Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).

Regeneron Pharmaceuticals (BSP:REGN34) Headlines

No Headlines